Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2019 | MR Linac: benefits, usage & research collaborations

Fiona McDonald • 24 Jan 2019
BTOG 2019
General Lung Cancer Non-Small Cell Lung Cancer

The MR Linac is an exciting new development in the field of radiotherapy. Here, Fiona McDonald, MA, MBBS, MRCP, FRCR, MD, of the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK, discusses it’s benefits, current usage in the UK and research collaborations with centers abroad. This interview took place at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.

More from Fiona McDonald

2:21
Radical treatment for oligometastatic NSCLC
Fiona McDonald • 24 Jan 2019

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:38
Phase I trial of binimetinib and pembrolizumab in NSCLC
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals